Tobramycin Dexamethasone
TOBRADEX ST ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.
United States
$258
per month
India
$2
per month
You save
−99.30%save $256/mo · 99.30% cheaper
599.6K US scripts/yr$153.6M potential annual savings$154.7M US spend/yr
Drag to rotate · 3D structureC18H37N5O9
SMILES: C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N
Compare the price
US price$258per month
India price$2per month
You save$25699.30% less
Based on 30 units per month. US $8.60 vs India $0.06 per unit.
Total over 1 periodSave $256$258 → $2
The bigger picture
Tobramycin Dexamethasone is filled about 599.6K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$154.7M
If sourced from India
$1.1M
Potential annual savings
$153.6M
−99%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.